skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PharmaLogo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

Issue 

Our client was developing a product for the treatment of Tardive Dyskinesia (TD) and Tourette’s Syndrome (TS). The client was looking to develop a deeper understanding of the payer landscape in Europe and Japan as part of an overall market opportunity assessment

Approach

  • We leveraged all proprietary and public data sources and collated existing data provide by the client.
  • We conducted primary market research with treating physicians and payers (n=30) in the form of TDIs lasting 45 minutes.

Outcome

  • The output of this project entailed a comprehensive disease assessment which provided our client with actionable insights around patient dynamics, current and future disease management, unmet needs and competitive environment
  • The client used our analysis to inform pricing & reimbursement decisions for their project in the geographies of interest
  • Our analysis further informed the client’s positioning strategies and decisions on how to differentiate their product against competitors

 

Qualitative Market Research with Payers in the EU and Japan from Pharma Intelligence

Next steps

For a personal discussion, please contact Richard Veal:  

richard.veal@informa.com
General enquiry

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now